The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges
Open accessAbstract
Over the past decades, mesenchymal stem cell (MSC)-based therapy has been intensively investigated and shown promising results in the treatment of various diseases due to their easy isolation, multiple lineage differentiation potential and immunomodulatory effects. To date, hundreds of phase I and II clinical trials using MSCs have been completed and many are ongoing. Accumulating evidence has shown that transplanted allogeneic MSCs lose their beneficial effects due to immunorejection. Nevertheless, the function of autologous MSCs is adversely affected by age, a process termed senescence, thus limiting their therapeutic potential. Despite great advances in knowledge, the potential mechanisms underlying MSC senescence are not entirely clear. Understanding the molecular mechanisms that contribute to MSC senescence is crucial when exploring novel strategies to rejuvenate senescent MSCs. In this review, we aim to provide an overview of the biological features of senescent MSCs and the recent progress made regarding the underlying mechanisms including epigenetic changes, autophagy, mitochondrial dysfunction and telomere shortening. We also summarize the current approaches to rejuvenate senescent MSCs including gene modification and pretreatment strategies. Collectively, rejuvenation of senescent MSCs is a promising strategy to enhance the efficacy of autologous MSC-based therapy, especially in elderly patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“Each spot represents condensed chromatin that is transcriptionally inactive, and expression of some transcription factors around this region have been found to be downregulated, such as E2F family members and cyclin A (Narita, 2003).”
BackgroundRubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · cited 1×
“Autophagy gradually loses its function with the growth of age, efficiency also decreases (Rubinsztein, 2011).”
BackgroundFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 1×
“The SASP factors include interleukin-1 (IL-1), IL-6, IL8, matrix metalloproteinase1 (MMP1), TNF-α and vascular endothelial growth factor (VEGF) and so on (Rodier and Campisi, 2011).”
BackgroundDebacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. (2009) · Nature Protocols · doi:10.1038/nprot.2009.191 · Cited by 1,668
From discoveries in ageing research to therapeutics for healthy ageing
Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E. (2019) · Nature · doi:10.1038/s41586-019-1365-2 · Cited by 1,389 · cited 1×
“Current evidence indicates that IIS signaling plays a key role in regulating aging and longevity (Campisi, 2019).”
BackgroundMechanisms and functions of cellular senescence
Herranz, N., & Gil, J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95148 · Cited by 1,232 · cited 1×
“The disturbed mitochondrial dynamics that occurs in cellular senescence affects morphology of MSCs (Herranz and Gil, 2018).”
BackgroundStolzing, A., Jones, E., McGonagle, D., & Scutt, A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.12.002 · Cited by 1,195
Autophagy mediates the mitotic senescence transition
Young, A. R. J., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J. F. J., Tavaré, S., Arakawa, S., Shimizu, S., Watt, F. M., et al. (2009) · Genes & Development · doi:10.1101/gad.519709 · Cited by 1,078
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028 · cited 1×
“First reported in 2006, induced pluripotent stem cells (iPSCs) have been established as useful tools for regenerative medicine (Marion, 2009; Frobel, 2014).”
BackgroundIn Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988 · cited 1×
“Partial reprogramming is similarly regarded as epigenetic rejuvenation and involves DNA methylation and histone modification (Ocampo, 2016).”
BackgroundStem cell aging: mechanisms, regulators and therapeutic opportunities
Oh, J., Lee, Y. D., & Wagers, A. J. (2014) · Nature Medicine · doi:10.1038/nm.3651 · Cited by 796 · cited 1×
“Three signal pathways, insulin-like signaling pathway, target of rapamycin and Sirtuins/NAD +, have been shown to play a major role in MSC senescence (Severino et al., 2013; Gharibi, 2014; Oh, 2014; Chen, 2017).”
BackgroundLinking functional decline of telomeres, mitochondria and stem cells during ageing
Sahin, E., & DePinho, R. A. (2010) · Nature · doi:10.1038/nature08982 · Cited by 759 · cited 1×
“At the same time, ROS is an important factor that affects MSC senescence (Sahin and Depinho, 2010; Ghanta, 2017).”
BackgroundToussaint, O., Medrano, E. E., & von Zglinicki, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00180-7 · Cited by 713
Bmi1, stem cells, and senescence regulation
Park, I.-K., Morrison, S. J., & Clarke, M. F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420800 · Cited by 495
Osteogenesis and aging: lessons from mesenchymal stem cells
Infante, A., & Rodríguez, C. I. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0995-x · Cited by 334
Watanabe, S., Kawamoto, S., Ohtani, N., & Hara, E. (2017) · Cancer Science · doi:10.1111/cas.13184 · Cited by 321 · cited 1×
“The senescent features of MSCs include enlarged and more granular morphology, and a deficient capacity for proliferation (Haynesworth, 1997) and differentiation, and secretion of a variety molecules, referred to as a “senescence-associated secretory phenotype (SASP)” (Watanabe, 2017).”
BackgroundÖzcan, S., Alessio, N., Acar, M. B., Mert, E., Omerli, F., Peluso, G., & Galderisi, U. (2016) · Aging · doi:10.18632/aging.100971 · Cited by 295
Telomere Length: A Review of Methods for Measurement
Montpetit, A. J., Alhareeri, A. A., Montpetit, M., Starkweather, A. R., Elmore, L. W., Filler, K., Mohanraj, L., Burton, C. W., Menzies, V. S., Lyon, D. E., et al. (2014) · Nursing Research · doi:10.1097/nnr.0000000000000037 · Cited by 293
Kosar, M., Bartkova, J., Hubackova, S., Hodny, Z., Lukas, J., & Bartek, J. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14707 · Cited by 283
Severino, V, Alessio, N., Farina, A., Sandomenico, A., Cipollaro, M., Peluso, G., Galderisi, U., & Chambery, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.445 · Cited by 214
Senescent cells: a therapeutic target for cardiovascular disease
Childs, B. G., Li, H., & van Deursen, J. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95146 · Cited by 192 · cited 2×
“During the gradual process of MSC senescence, DNMT1 and DNMT3B have been shown to be downregulated with a consequent decrease in DNA methylation (Childs, 2018).”
BackgroundTechniques to induce and quantify cellular senescence
Noren Hooten, N., & Evans, M. K. (2017) · Journal of Visualized Experiments · doi:10.3791/55533 · Cited by 178
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence
Patel, P. L., Suram, A., Mirani, N., Bischof, O., & Herbig, U. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602379113 · Cited by 142 · cited 1×
“Overexpression of the enzymatic subunit of telomerase, telomerase reverse transcriptase (TERT), increases median lifespan in mice (Patel, 2016).”
BackgroundKornienko, J. S., Smirnova, I. S., Pugovkina, N. A., Ivanova, J. S., Shilina, M. A., Grinchuk, T. M., Shatrova, A. N., Aksenov, N. D., Zenin, V. V., Nikolsky, N. N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37972-y · Cited by 135 · cited 2×
“Numerous stress stimuli also trigger senescence, known as stress-induced senescence (Kornienko, 2019).”
BackgroundLee, J. H., Yoon, Y. M., Song, K., Noh, H., & Lee, S. H. (2020) · Aging Cell · doi:10.1111/acel.13111 · Cited by 97
Khanh, V. C., Zulkifli, A. F., Tokunaga, C., Yamashita, T., Hiramatsu, Y., & Ohneda, O. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.136 · Cited by 81
Cited by
Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
Weng, Z., Wang, Y., Ouchi, T., Liu, H., Qiao, X., Wu, C., Zhao, Z., Li, L., & Li, B. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac004 · Cited by 285
Li, M., Jiang, Y., Hou, Q., Zhao, Y., Zhong, L., & Fu, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02822-2 · Cited by 119
Senescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy
Liu, Y., & Chen, Q. (2020) · Current Molecular Biology Reports · doi:10.1007/s40610-020-00141-0 · Cited by 41
Savvidou, M. G., Georgiopoulou, I., Antoniou, N., Tzima, S., Kontou, M., Louli, V., Fatouros, C., Magoulas, K., & Kolisis, F. N. (2023) · Plants · doi:10.3390/plants12020361 · Cited by 20
Fard, A. T., Leeson, H., Perez, J. A., Pietrogrande, G., Power, D., Inclan, C. L. G., Zheng, H., Nelson, C., Soheilmoghaddam, F., Glass, N., et al. (2022) · doi:10.1101/2022.01.24.476823 · Cited by 3
“Bulk MSC cultures also exhibit notable changes in chromatin organisation and gene expression as these cells undergo replicative senescence [9].”
Background
Metadata
- Authors
- Zhou, X., Hong, Y., Zhang, H., & Li, X.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-03
- Volume
- 8
- Pages
- 364-364
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3033413956
- Cited by
- 167
- References
- 28
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.